In a snap­shot of its rare dis­ease da­ta, Ul­tragenyx boosts case for new sur­ro­gate bio­mark­er

Ul­tragenyx took a step to­ward es­tab­lish­ing a po­ten­tial new sur­ro­gate bio­mark­er Tues­day morn­ing, pre­sent­ing da­ta for a rare dis­ease with no ap­proved treat­ments.

Re­searchers are …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.